Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Galapagos NV ADR (GLPG)

Galapagos NV ADR (GLPG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,955,624
  • Shares Outstanding, K 65,523
  • Annual Sales, $ 605,720 K
  • Annual Income, $ -348,900 K
  • 60-Month Beta 0.55
  • Price/Sales 6.50
  • Price/Cash Flow N/A
  • Price/Book 1.21
Trade GLPG with:

Options Overview

Details
  • Implied Volatility 46.80%
  • Historical Volatility 55.99%
  • IV Percentile 41%
  • IV Rank 38.43%
  • IV High 68.39% on 08/19/20
  • IV Low 33.33% on 04/21/21
  • Put/Call Vol Ratio 4.06
  • Today's Volume 268
  • Volume Avg (30-Day) 192
  • Put/Call OI Ratio 2.34
  • Today's Open Interest 9,811
  • Open Int (30-Day) 13,922

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -1.47
  • Number of Estimates 5
  • High Estimate -0.90
  • Low Estimate -2.03
  • Prior Year -1.95
  • Growth Rate Est. (year over year) +24.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.79 +6.30%
on 07/16/21
71.81 -15.93%
on 06/28/21
-11.68 (-16.21%)
since 06/25/21
3-Month
56.79 +6.30%
on 07/16/21
81.12 -25.58%
on 06/10/21
-20.74 (-25.57%)
since 04/27/21
52-Week
56.79 +6.30%
on 07/16/21
195.74 -69.16%
on 08/13/20
-135.44 (-69.17%)
since 07/27/20

Most Recent Stories

More News
Galapagos (GLPG) Falls on Inflammatory Study Data Readout

Galapagos (GLPG) announces data from multiple studies evaluating its two inflammatory candidates - GLPG3970 and GLPG3667. Stock down.

GILD : 68.93 (+0.26%)
ALXN : 182.50 (+1.70%)
ADPT : 35.42 (-3.80%)
GLPG : 60.37 (+0.48%)
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation

- Biologic effect of salt inducible kinase (SIK) mechanism in first patient studies supports further progression of Toledo portfolio

GLPG : 60.37 (+0.48%)
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study

- Generally safe and well tolerated

GLPG : 60.37 (+0.48%)
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis

New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn's and Colitis Organisation (ECCO) virtual congress

GLPG : 60.37 (+0.48%)
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Galapagos announces departure of CSO Piet Wigerinck later this year

Mechelen, Belgium; 22 June 2021, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces the departure of Dr. Piet Wigerinck later this year.

GLPG : 60.37 (+0.48%)
Galapagos increases share capital through subscription right exercises

Mechelen, Belgium; 7 June 2021, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from subscription right exercises.

GLPG : 60.37 (+0.48%)
SELECTION study on filgotinib in ulcerative colitis published in The Lancet

Mechelen, Belgium; 4 June 2021; 07.01 CET; - Galapagos NV (Euronext & Nasdaq: GLPG) today announced that primary and secondary endpoint results from the phase 3 SELECTION induction and maintenance study...

GLPG : 60.37 (+0.48%)
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress

Mechelen, Belgium, 27 May 2021, 22:01 CET, - Galapagos NV (Euronext & Nasdaq: GLPG) today announced that 15 abstracts, including scientific updates, and data providing further understanding on the profile...

GLPG : 60.37 (+0.48%)
US Pain Relief Therapeutics Market Share 2021 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2027

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Galapagos NV is a biotechnology company. The Company's operating segment consists of Research and Development and Services. Research and Development segment is engaged in the discovery and development of small molecules. Services segment offers drug discovery products and services. Its products include...

See More

Key Turning Points

3rd Resistance Point 62.24
2nd Resistance Point 61.40
1st Resistance Point 60.88
Last Price 60.37
1st Support Level 59.52
2nd Support Level 58.68
3rd Support Level 58.16

See More

52-Week High 195.74
Fibonacci 61.8% 142.66
Fibonacci 50% 126.26
Fibonacci 38.2% 109.87
Last Price 60.37
52-Week Low 56.79

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar